291 related articles for article (PubMed ID: 15023472)
1. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles.
Venkateswarlu V; Manjunath K
J Control Release; 2004 Mar; 95(3):627-38. PubMed ID: 15023472
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of nitrendipine solid lipid nanoparticles.
Manjunath K; Venkateswarlu V; Hussain A
Pharmazie; 2011 Mar; 66(3):178-86. PubMed ID: 21553647
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration.
Manjunath K; Venkateswarlu V
J Control Release; 2005 Oct; 107(2):215-28. PubMed ID: 16014318
[TBL] [Abstract][Full Text] [Related]
4. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
Liu J; Gong T; Wang C; Zhong Z; Zhang Z
Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
[TBL] [Abstract][Full Text] [Related]
5. Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin.
Abul Kalam M; Sultana Y; Ali A; Aqil M; Mishra AK; Aljuffali IA; Alshamsan A
J Biomed Mater Res A; 2013 Jun; 101(6):1813-27. PubMed ID: 23255511
[TBL] [Abstract][Full Text] [Related]
6. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
Attama AA; Müller-Goymann CC
Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
[TBL] [Abstract][Full Text] [Related]
7. Non-destructive methods of characterization of risperidone solid lipid nanoparticles.
Rahman Z; Zidan AS; Khan MA
Eur J Pharm Biopharm; 2010 Sep; 76(1):127-37. PubMed ID: 20470882
[TBL] [Abstract][Full Text] [Related]
8. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
[TBL] [Abstract][Full Text] [Related]
9. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
10. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
Liu CH; Wu CT; Fang JY
Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
[TBL] [Abstract][Full Text] [Related]
11. Controlled release of clozapine through chitosan microparticles prepared by a novel method.
Agnihotri SA; Aminabhavi TM
J Control Release; 2004 Apr; 96(2):245-59. PubMed ID: 15081216
[TBL] [Abstract][Full Text] [Related]
12. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
Vivek K; Reddy H; Murthy RS
AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
[TBL] [Abstract][Full Text] [Related]
13. [Preparation of solid lipid nanoparticles by microemulsion technique].
Mao SR; Wang YZ; Ji HY; Bi DZ
Yao Xue Xue Bao; 2003 Aug; 38(8):624-6. PubMed ID: 14628457
[TBL] [Abstract][Full Text] [Related]
14. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting.
Aji Alex MR; Chacko AJ; Jose S; Souto EB
Eur J Pharm Sci; 2011 Jan; 42(1-2):11-8. PubMed ID: 20971188
[TBL] [Abstract][Full Text] [Related]
15. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
[TBL] [Abstract][Full Text] [Related]
16. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.
Das S; Ng WK; Kanaujia P; Kim S; Tan RB
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):483-9. PubMed ID: 21831615
[TBL] [Abstract][Full Text] [Related]
17. Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the alpha-modification.
Rosenblatt KM; Bunjes H
Mol Pharm; 2009; 6(1):105-20. PubMed ID: 19049318
[TBL] [Abstract][Full Text] [Related]
18. Stability of lipid excipients in solid lipid nanoparticles.
Radomska-Soukharev A
Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
[TBL] [Abstract][Full Text] [Related]
19. Solid lipid nanoparticles (SLN) for topical drug delivery: incorporation of the lipophilic drugs N,N-diethyl-m-toluamide and vitamin K.
Işcan Y; Wissing SA; Hekimoğlu S; Müller RH
Pharmazie; 2005 Dec; 60(12):905-9. PubMed ID: 16398266
[TBL] [Abstract][Full Text] [Related]
20. Characterization and stability of nanostructured lipid carriers as drug delivery system.
Abbasalipourkabir R; Salehzadeh A; Abdullah R
Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
